3

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: May 16, 2016
Period of Report: May 16, 2016
Accession Number: 0001127602-16-052311

View Document ↗ View on SEC.gov ↗